A Phase 1/1b Study of ZH9 Treatment in Patients with Non-Muscle Invasive Bladder Cancer

Recruiting

Phase 1

A Phase 1/1b Study of ZH9 Treatment in Patients with Non-Muscle Invasive Bladder CancerA Phase 1/1b Study of ZH9 Treatment in Patients with Non-Muscle Invasive Bladder Cancer

Sponsor:

Prokarium Ltd

Code:

NCT06181266

Conditions

NMIBC

High Risk NMIBC

Non Muscle Invasive Bladder Cancer

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

ZH9

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information